 |
|
Boston Univeristy bioengineers devise 'dimmer swith' to regulate gene expression in mammal cells
July 27, 2007Three Boston University biomedical engineers have created a genetic dimmer switch that can be used to turn on, shut off, or partially activate a gene's function. Professor James Collins, Professor Charles Cantor and doctoral candidate Tara Deans invented the switch, which can be tuned to produce large or small quantities of protein, or none at all.
The research detailing their new switch, "A Tunable Genetic Switch Based on RNAi and Repressor Proteins for Regulating Gene Expression in Mammalian Cells," appears in the July 27 issue of Cell.
This switch helps advance the field of synthetic biology, which rests on the premise that complex biological systems can be built by arranging components or standard parts, as an electrician would to build an electric light switch. Much work in the field to date uses bacteria or yeast, but the Boston University team used more complex mammalian cells, from hamsters and mice. The switch has several new design features that extend possible applications into areas from basic research to gene therapy.
"There are a number of technologies available to regulate gene expression, but they each come with limitations," said Collins. "One of the central problems is you can't get a really tight 'off' state."
Even when genetic switches are turned off, a trickle of the protein that is meant to be repressed still gets made. Some genetic switches get around this by entirely snipping out a gene to stop production of a specific protein, but this approach is irreversible.
To overcome these challenges, "Tara came up with a design that really combined two different technologies to repress or shut down gene expression," Collins added. "We said, okay, we've got these two technologies, both that give a pretty good 'off,' why not try to combine them together to get a really clear and strong 'off,'" said Collins.
The first strategy, a repressor protein, sits on DNA like a roadblock, preventing any gene product -- messenger RNA (mRNA) -- from being made. If any mRNA gets past this repressor, the second technique, interfering RNA (RNAi) attaches to the functional mRNA, rendering it useless. The cell cannot turn it into protein.
"I was delighted to see that when the two systems are coupled, it is possible to completely turn a gene's function off," said Deans.
This switch is also reversible and tunable. By adding a chemical -- Isopropyl-â-thiogalactopyranoside -- the repressor components are blocked and the gene turns on again. The gene's activity can be tuned up or down by adjusting the amount of this chemical.
The researchers demonstrated the strength of their "off" switch by hooking it up to the gene for diphtheria toxin, then inserting it into cells. One molecule of diphtheria toxin can kill a cell, but with the genetic switch turned off, the cells survived for weeks. When the researchers flipped the switch, toxin production was triggered and the cell died.
They also showcased the switch's capability for delicately tuning gene expression, by installing it alongside a gene that leads to apoptosis, programmed cell death, once a certain threshold concentration of the gene's product is reached. They gradually increased the gene's activity until they met and passed this threshold.
This tuning feature is important, said Deans, because "many diseases are not a result of missing a gene, but rather a result of too much or too little expression. With the ability to tune the level of gene expression in our switch, we could explore threshold responses and how these result in disease phenotypes."
The switch may also hold promise for therapeutic applications. "It gives a really nice regulator scheme for cell and gene therapy," said Collins. "I think in the coming decades we'll increasingly see these therapies being introduced as part of routine medical practice."
Boston University
"There are a number of technologies available to regulate gene expression, but they each come with limitations," said Collins. "One of the central problems is you can't get a really tight 'off' state."
Even when genetic switches are turned off, a trickle of the protein that is meant to be repressed still gets made. Some genetic switches get around this by entirely snipping out a gene to stop production of a specific protein, but this approach is irreversible.
To overcome these challenges, "Tara came up with a design that really combined two different technologies to repress or shut down gene expression," Collins added. "We said, okay, we've got these two technologies, both that give a pretty good 'off,' why not try to combine them together to get a really clear and strong 'off,'" said Collins.
The first strategy, a repressor protein, sits on DNA like a roadblock, preventing any gene product -- messenger RNA (mRNA) -- from being made. If any mRNA gets past this repressor, the second technique, interfering RNA (RNAi) attaches to the functional mRNA, rendering it useless. The cell cannot turn it into protein.
"I was delighted to see that when the two systems are coupled, it is possible to completely turn a gene's function off," said Deans.
This switch is also reversible and tunable. By adding a chemical -- Isopropyl-â-thiogalactopyranoside -- the repressor components are blocked and the gene turns on again. The gene's activity can be tuned up or down by adjusting the amount of this chemical.
The researchers demonstrated the strength of their "off" switch by hooking it up to the gene for diphtheria toxin, then inserting it into cells. One molecule of diphtheria toxin can kill a cell, but with the genetic switch turned off, the cells survived for weeks. When the researchers flipped the switch, toxin production was triggered and the cell died.
They also showcased the switch's capability for delicately tuning gene expression, by installing it alongside a gene that leads to apoptosis, programmed cell death, once a certain threshold concentration of the gene's product is reached. They gradually increased the gene's activity until they met and passed this threshold.
This tuning feature is important, said Deans, because "many diseases are not a result of missing a gene, but rather a result of too much or too little expression. With the ability to tune the level of gene expression in our switch, we could explore threshold responses and how these result in disease phenotypes."
The switch may also hold promise for therapeutic applications. "It gives a really nice regulator scheme for cell and gene therapy," said Collins. "I think in the coming decades we'll increasingly see these therapies being introduced as part of routine medical practice."
Boston University
Gene Expression Current Events and Gene Expression News RSSNew gene silencing pathway found in plants
Biologists at Washington University in St. Louis have made major headway in explaining a mechanism by which plant cells silence potentially harmful genes.
Biomedical engineers' detective work reveals antibiotic mechanism
A series of genetic clues led a team of Boston University biomedical engineers to uncover exactly how certain antibiotics kill bacteria. The findings could help rejuvenate the efficacy of older antibiotics and reveal new antibiotic targets within bacterial cells.
Pivotal Emory study focuses on teens at risk for psychosis
Emory University in Atlanta is playing a key role in the largest, most comprehensive study ever funded by the National Institute of Mental Health (NIMH) of adolescents and young adults at risk for developing a psychotic disorder.
Social interactions can alter gene expression in the brain, and vice versa
Our DNA determines a lot about who we are and how we play with others, but recent studies of social animals (birds and bees, among others) show that the interaction between genes and behavior is more of a two-way street than most of us realize.
Scripps research scientists identify compounds for stem-cell production from adult cells
In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects.
New research finds markers for esophageal cancer before it develops
Rhode Island Hospital researchers have identified genetic proteins, also known as biomarkers, capable of distinguishing changes at the microscopic level that can signal a precancerous condition in the esophagus.
Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows
Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests.
Researchers Apply Systems Biology and Glycomics to Study Human Inflammatory Diseases
An innovative systems biology approach to understanding the carbohydrate structures in cells is leading to new ways to understand how inflammatory illnesses and cardiovascular disease develop in humans. The work was described in two recent publications by University at Buffalo chemical engineers.
First comprehensive genomic study of common cold reveals new treatment targets
Today, scientists from Procter & Gamble (P&G), the University of Calgary and the University of Virginia announced results from the first study to examine the entire human genome's response to the most common cold virus, human rhinovirus.
Novel marker of colon cancer
Colon cancer ranks second of all gastrointestinal malignant tumors, it is one of the leading causes of cancer-related deaths worldwide.
More Gene Expression Current Events and Gene Expression News Articles
 | Gene Expression and Regulation by Jun Ma This book offers a comprehensive look into the science of gene expression and regulation. Focusing on topics such as actions of nuclear receptors, RNA processing, and DNA methylation and imprinting, Gene Expression and Regulation is edited by a leading biologist and includes contributions by experts in the field. Presented in the following five sections, this book covers a full spectrum of... |
| Methods in Neurosciences: Neuropeptide Technology Gene Expression and Neuropeptide Receptors (Methods in Neurosciences) | |
 | Cloning, Gene Expression, and Protein Purification: Experimental Procedures and Process Rationale by Charles Hardin, Jennifer Edwards, Andrew Riell, David Presutti, William Miller, Dominique Robertson On the forefront of modern scientific innovation, Cloning, Gene Expression and Protein Purification: Experimental Procedures and Process Rationale effectively doubles as a laboratory manual for students and a reference book for professional researchers. Designed for advanced undergraduate and beginning graduate students in molecular biology, this unique combination lecture/laboratory resource... |
 | Statistical Analysis of Gene Expression Microarray Data Although less than a decade old, the field of microarray data analysis is now thriving and growing at a remarkable pace. Biologists, geneticists, and computer scientists as well as statisticians all need an accessible, systematic treatment of the techniques used for analyzing the vast amounts of data generated by large-scale gene expression studies. And there is arguably no group better... |
 | Advanced Analysis of Gene Expression Microarray Data (Science, Engineering, and Biology Informatics) by Aidong Zhang This book focuses on the development and application of the latest advanced data mining, machine learning, and visualization techniques for the identification of interesting, significant, and novel patterns in gene expression microarray data. Biomedical researchers will find this book invaluable for learning the cutting-edge methods for analyzing gene expression microarray data. Specifically, the... |
 | Bayesian Inference for Gene Expression and Proteomics by Marina Vannucci The interdisciplinary nature of bioinformatics presents a challenge in integrating concepts, methods, software, and multi-platform data. Although there have been rapid developments in new technology and an inundation of statistical methodology and software for the analysis of microarray gene expression arrays, there exist few rigorous statistical methods for addressing other types of... |
 | Measuring Gene Expression (Basics (Routledge Paperback)) by Matthew Avison In the post-genomic age, much biomedical research looks at when, where, and at what level genes are expressed. Measuring Gene Expression: The Basics is an all-in-one introduction to the main methods of measuring gene expression, including RT-PCR, differential display, RNA interference, reporter genes, microarrays, and proteomics, as well as a section on RNA isolation and analysis. There will be... |
 | RNA and the Regulation of Gene Expression: A Hidden Layer of Complexity |
 | Regulation of Gene Expression by Gary H. Perdew, Jack P. Vanden Heuvel, Jeffrey M. Peters Regulation of Gene Expression: Molecular Mechanisms presents a comprehensive overview of methods and approaches for characterizing mechanisms of gene regulation. The text is appropriate both as a graduate textbook and a standard laboratory reference and provides the essential groundwork for an advanced understanding of the various mechanisms that may result in altered activity of a specific cell... |
 | Control of Gene Expression by Catecholamines and the Renin-Angiotensin System The special issue of Molecular and Cellular Biochemistry focuses on `Control of Gene Expression by Catecholamines and the Renin-Angiotensin System' in health and disease. In recent years, great progress has been made in the understanding of catecholamine and angiotensin II modulated gene expression. There is also increasing evidence that catecholamine and angiotensin II induced cellular... |
| © 2008 BrightSurf.com |